EDGAR Filing Documents for 0001144204-13-066566

Form 8-K - Current report:

SEC Accession No. 0001144204-13-066566

Filing Date

2013-12-10

Accepted

2013-12-10 16:51:46

Documents

Period of Report

2013-12-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v362603_8k.htm	8-K	32479
2	EXHIBIT 10.1	v362603_ex10-1.htm	EX-10.1	320150
3	EXHIBIT 10.2	v362603_ex10-2.htm	EX-10.2	57760
4	EXHIBIT 10.3	v362603_ex10-3.htm	EX-10.3	62353
5	EXHIBIT 10.4	v362603_ex10-4.htm	EX-10.4	78082
6	EXHIBIT 10.5	v362603_ex10-5.htm	EX-10.5	77805
7	EXHIBIT 99.1	v362603_ex99-1.htm	EX-99.1	15777
8	EXHIBIT 99.2	v362603_ex99-2.htm	EX-99.2	19521
9	GRAPHIC	tex99-1logo.jpg	GRAPHIC	21893
10	GRAPHIC	tex99-2logo.jpg	GRAPHIC	14293
	Complete submission text file	0001144204-13-066566.txt		715524

Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850

Business Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850 (734) 332-7800

Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)